Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

A Fluorescence-Based Assay Using Engineered Lymphocytes for Screening Immunomodulatory Compounds02:57

A Fluorescence-Based Assay Using Engineered Lymphocytes for Screening Immunomodulatory Compounds

563
This video demonstrates the screening of immunomodulatory compounds via fluorescent-based assay. Transgenic mouse-derived T lymphocytes with green fluorescent protein expression cassettes are treated with these compounds. The enhanced and reduced GFP signals enable the identification of the compounds' stimulatory and inhibitory effects,...
563
Effect of an Immunomodulatory Pharmacological Agent on the Interaction Between Dendritic Cells and CD4+ T Cells02:40

Effect of an Immunomodulatory Pharmacological Agent on the Interaction Between Dendritic Cells and CD4+ T Cells

583
This video demonstrates a method of converting dendritic cells (DCs) to tolerogenic DCs (TolDCs) using an immunomodulatory pharmacological agent. This conversion is confirmed by evaluating the TolDC function through their immunosuppressive effect on CD4+ T...
583
An In Vitro Assay for Evaluating the Immunomodulatory Impact of Monocytes on Leukocyte Proliferation02:46

An In Vitro Assay for Evaluating the Immunomodulatory Impact of Monocytes on Leukocyte Proliferation

496
This video demonstrates an in vitro assay to explore the immunomodulatory influence of mesenchymal stem cells (MSCs) on effector T cell proliferation. The assay includes co-culturing MSCs with PBMCs to induce the monocyte population to acquire an immunomodulatory phenotype, leading to the secretion of interleukin-10 (IL-10). Following incubation with activated CD4+ T cells, the induced monocytes effectively suppress T cell...
496
Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells (MSCs)06:20

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells (MSCs)

12.8K
The immunomodulatory properties of human mesenchymal stem cells (MSC) appear increasingly relevant for clinical application. Using a co-culture system of MSCs and peripheral blood leukocytes pre-stained with the fluorescent dye carboxyfluorescein succinimidyl ester (CFSE), we describe the in vitro assessment of MSC immunomodulation on effector leukocyte proliferation and specific...
12.8K
Rapid Quantification of Mitogen-induced Blastogenesis in T Lymphocytes for Identifying Immunomodulatory Drugs08:13

Rapid Quantification of Mitogen-induced Blastogenesis in T Lymphocytes for Identifying Immunomodulatory Drugs

19.4K
T-lymphocyte mitogenesis is accompanied by blastogenic transformation, whereupon the cell volume enlarges before cell division. Here, we describe a method to quantify blastogenesis in T lymphocytes using an automated cell counter with the capability of measuring cell diameters.
19.4K
Evaluating the Anti-Tumor Efficacy of a Bacterial Immunomodulatory Protein in a Murine Model02:12

Evaluating the Anti-Tumor Efficacy of a Bacterial Immunomodulatory Protein in a Murine Model

425
This video demonstrates a technique to assess the anti-tumor activity of Helicobacter pylori neutrophil-activating protein, or HP-NAP, in a mouse bladder cancer model. HP-NAP interacts with tumor-cell neutrophils to produce pro-inflammatory cytokines, inducing the differentiation of naïve T cells into type 1 T helper (Th1) and type 1 cytotoxic (Tc1) T cell phenotypes. The Th1 and Tc1 cells secrete interferon-gamma, inhibiting tumor angiogenesis and promoting cytotoxic T cell-mediated tumor...
425

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gestational Exposure to 10 Classes of Priority Chemicals and Birth Outcomes in the ECHO Cohort.

JAMA network open·2026
Same author

[A population-based survey of myopia on primary school students in an administrative district, 2019 to 2024].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences·2026
Same author

Vehicle Detection in Drone Aerial Views Based on Lightweight YOLOv10-IAD.

Sensors (Basel, Switzerland)·2026
Same author

Immunologically Effective Chiral Polymers to Potentiate Anti-Cancer Immune Responses.

Polymer science & technology (Washington, D.C.)·2026
Same author

Synthetic Polymers for Drug, Gene, and Vaccine Delivery.

Polymer science & technology (Washington, D.C.)·2026
Same author

Prospects of Four-Dimensional Printing of Polymers for Biomedical Engineering.

Polymer science & technology (Washington, D.C.)·2026

Related Experiment Video

Updated: Jan 19, 2026

A Fluorescence-Based Assay Using Engineered Lymphocytes for Screening Immunomodulatory Compounds
02:57

A Fluorescence-Based Assay Using Engineered Lymphocytes for Screening Immunomodulatory Compounds

563

Immunomodulatory Nanosystems.

Xiangru Feng1,2, Weiguo Xu1, Zhongmin Li1,3

  • 1Key Laboratory of Polymer Ecomaterials Changchun Institute of Applied Chemistry Chinese Academy of Sciences Changchun 130022 P. R. China.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|September 12, 2019
PubMed
Summary
This summary is machine-generated.

Nanotechnology enhances immunotherapy by improving immune stimulation and reducing side effects for treating cancer, infections, and autoimmune diseases. This review covers recent advances in nanomaterials for both immunostimulation and immunosuppression.

Keywords:
disease treatmentimmunostimulationimmunosuppressionimmunotherapynanotechnology

More Related Videos

Effect of an Immunomodulatory Pharmacological Agent on the Interaction Between Dendritic Cells and CD4+ T Cells
02:40

Effect of an Immunomodulatory Pharmacological Agent on the Interaction Between Dendritic Cells and CD4+ T Cells

583
An In Vitro Assay for Evaluating the Immunomodulatory Impact of Monocytes on Leukocyte Proliferation
02:46

An In Vitro Assay for Evaluating the Immunomodulatory Impact of Monocytes on Leukocyte Proliferation

496

Related Experiment Videos

Last Updated: Jan 19, 2026

A Fluorescence-Based Assay Using Engineered Lymphocytes for Screening Immunomodulatory Compounds
02:57

A Fluorescence-Based Assay Using Engineered Lymphocytes for Screening Immunomodulatory Compounds

563
Effect of an Immunomodulatory Pharmacological Agent on the Interaction Between Dendritic Cells and CD4+ T Cells
02:40

Effect of an Immunomodulatory Pharmacological Agent on the Interaction Between Dendritic Cells and CD4+ T Cells

583
An In Vitro Assay for Evaluating the Immunomodulatory Impact of Monocytes on Leukocyte Proliferation
02:46

An In Vitro Assay for Evaluating the Immunomodulatory Impact of Monocytes on Leukocyte Proliferation

496

Area of Science:

  • Nanotechnology
  • Immunotherapy
  • Materials Science

Background:

  • Immunotherapy is a key treatment for cancer, infections, and autoimmune diseases.
  • Immunomodulatory nanosystems offer solutions to immunotherapy's limitations like poor immune response and side effects.
  • Nanomaterials are continuously evolving with novel structures and functions.

Purpose of the Study:

  • To review recent advances in nanotechnology for immunostimulation and immunosuppression.
  • To highlight the role of nanosystems in cancer immunotherapy, infectious diseases, and autoimmune disorders.
  • To discuss challenges and future prospects of nanotechnology in immunotherapy.

Main Methods:

  • Literature review of recent advances in nanotechnology for immunotherapy.
  • Analysis of nanosystem applications in cancer, infectious, inflammatory, and autoimmune diseases.
  • Discussion of nanomaterial design for immune modulation.

Main Results:

  • Nanosystems improve cancer immunotherapy by activating immune cells and modulating the tumor microenvironment.
  • Nanomaterial vaccines show promise against viral and bacterial infections.
  • Nanoparticles enhance immunosuppressive therapies for inflammatory and autoimmune diseases.

Conclusions:

  • Nanotechnology significantly advances immunotherapy by overcoming treatment obstacles.
  • Nanosystems are versatile tools for both stimulating and suppressing immune responses.
  • Further research into nanotechnology holds promise for future immunomodulatory therapies.